Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Bech (1988)
Rating scales for mood disorders: Applicability, Consistency and construct validityActa Psychiatrica Scandinavica, 78
R. Hansen, G. Gartlehner, K. Lohr, B. Gaynes, T. Carey (2005)
Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive DisorderAnnals of Internal Medicine, 143
M. Berlim, G. Turecki (2007)
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trialsEuropean Neuropsychopharmacology, 17
O. Berton, E. Nestler (2006)
New approaches to antidepressant drug discovery: beyond monoaminesNature Reviews Neuroscience, 7
M. Millan (2006)
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.Pharmacology & therapeutics, 110 2
A. Lammertsma, S. Hume (1996)
Simplified Reference Tissue Model for PET Receptor StudiesNeuroImage, 4
K. Ressler, H. Mayberg (2007)
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinicNature Neuroscience, 10
S. Montgomery, D. Baldwin, P. Blier, N. Fineberg, S. Kasper, M. Lader, R. Lam, J. Lépine, H. Möller, D. Nutt, F. Rouillon, A. Schatzberg, M. Thase (2007)
Which antidepressants have demonstrated superior efficacy? A review of the evidenceInternational Clinical Psychopharmacology, 22
J. Meyer (2007)
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.Journal of psychiatry & neuroscience : JPN, 32 2
N. Kabani, David MacDonald, C. Holmes, Alan Evans (1998)
3D Anatomical Atlas of the Human BrainNeuroImage, 7
K. Marthi, S. Jakobsen, D. Bender, S. Hansen, Stefan Smith, F. Hermansen, R. Rosenberg, Donald Smith (2004)
[N-methyl-11C]Mirtazapine for positron emission tomography neuroimaging of antidepressant actions in humansPsychopharmacology, 174
Donald Smith, B. Stork, G. Wegener, S. Jakobsen, D. Bender, H. Audrain, S. Jensen, S. Hansen, A. Rodell, R. Rosenberg (2007)
Receptor occupancy of mirtazapine determined by PET in healthy volunteersPsychopharmacology, 195
P Bech (1988)
Rating scales for mood disorders: applicability, consistency and construct validityActa Psychiatr Neurol Scand, 78
A. Rush, M. Thase, S. Dubé (2003)
Research issues in the study of difficult-to-treat depressionBiological Psychiatry, 53
M. Oquendo, J. Mann (2000)
The biology of impulsivity and suicidality.The Psychiatric clinics of North America, 23 1
C. Hercher, G. Turecki, N. Mechawar (2009)
Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression.Journal of psychiatric research, 43 11
Gordon Parker (2000)
Classifying depression: should paradigms lost be regained?The American journal of psychiatry, 157 8
F. Quitkin, B. Taylor, C. Kremer (2001)
Does mirtazapine have a more rapid onset than SSRIs?The Journal of clinical psychiatry, 62 5
David Wheatley, Miriam Moffaert, Leo Timmerman, Charlotte Kremer (1998)
Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.The Journal of clinical psychiatry, 59 6
Ingrid Johnsrude (2000)
Atlas of the Human BrainJournal of Psychophysiology, 14
B. Tabachnick, L. Fidell (1983)
Using Multivariate Statistics
Yun Zhou, C. Endres, James Brašić, Sung-Cheng Huang, D. Wong (2003)
Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue modelNeuroImage, 18
T. Petersen, G. Papakostas, M. Posternak, Alexis Kant, W. Guyker, D. Iosifescu, A. Yeung, A. Nierenberg, M. Fava (2005)
Empirical Testing of Two Models for Staging Antidepressant Treatment ResistanceJournal of Clinical Psychopharmacology, 25
A. Szegedi, Natascha Schwertfeger (2005)
Mirtazapine: a review of its clinical efficacy and tolerabilityExpert Opinion on Pharmacotherapy, 6
S. Anttila, E. Leinonen (2006)
A review of the pharmacological and clinical profile of mirtazapine.CNS drug reviews, 7 3
A Collignon, F Maes, D Delaere, D Vandermeulen, P Suetens, G Marchal (1995)
Information processing in medical imaging
J. Kent (2000)
SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depressionThe Lancet, 355
Donald Smith, S. Jakobsen (2009)
Molecular tools for assessing human depression by positron emission tomographyEuropean Neuropsychopharmacology, 19
F. Yasuno, A. Hasnine, T. Suhara, T. Ichimiya, Y. Sudo, M. Inoue, A. Takano, Tan Ou, Tomomichi Ando, H. Toyama (2002)
Template-Based Method for Multiple Volumes of Interest of Human Brain PET ImagesNeuroImage, 16
de Th, G. Maura, Maurizio Raiteri, de Cj, J. Wieringa, Pinder Rm (1988)
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomersNeuropharmacology, 27
D. Collins, P. Neelin, T. Peters, A. Evans (1994)
Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach SpaceJournal of Computer Assisted Tomography, 18
J. Russell, K. Hawkins, R. Ozminkowski, L. Orsini, W. Crown, S. Kennedy, S. Finkelstein, E. Berndt, A. Rush (2004)
The cost consequences of treatment-resistant depression.The Journal of clinical psychiatry, 65 3
G. Papakostas, M. Thase, M. Thase, M. Fava, J. Nelson, R. Shelton (2007)
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer AgentsBiological Psychiatry, 62
Donald Smith, S. Dyve, L. Minuzzi, S. Jakobsen, O. Munk, K. Marthi, P. Cumming (2006)
Inhibition of [11C]mirtazapine binding by α2‐adrenoceptor antagonists studied by positron emission tomography in living porcine brainSynapse, 59
P. Bech, P. Allerup, L. Gram, N. Reisby, R. Rosenberg, O. Jacobsen, Á. Nagy (1981)
The Hamilton Depression ScaleActa Psychiatrica Scandinavica, 63
W. Drevets, J. Savitz, M. Trimble (2008)
The Subgenual Anterior Cingulate Cortex in Mood DisordersCNS Spectrums, 13
A Bertelsen, T Brugha, AY Tien (1998)
Schedules for clinical assessment in neuropsychiatry. Version 2.1. Glossary. Differential definitions of SCAN items and commentary on the SCAN manual
V. Krishnan, E. Nestler (2008)
The molecular neurobiology of depressionNature, 455
T. Boer (1996)
The pharmacologic profile of mirtazapine.The Journal of Clinical Psychiatry, 57
M. Hamilton (1960)
A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 23
M. Millan, A. Gobert, J. Rivet, A. Adhumeau‐Auclair, D. Cussac, A. Newman-Tancredi, A. Dekeyne, J. Nicolas, F. Lejeune (2000)
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2‐adrenergic and serotonin2C receptors: a comparison with citalopramEuropean Journal of Neuroscience, 12
M. Fava (2003)
Diagnosis and definition of treatment-resistant depressionBiological Psychiatry, 53
P. Blier (2003)
The pharmacology of putative early-onset antidepressant strategiesEuropean Neuropsychopharmacology, 13
K. Marthi, D. Bender, A. Gjedde, Donald Smith (2002)
[11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brainEuropean Neuropsychopharmacology, 12
S. Montgomery, P. Reimitz, M. Zivkov (1998)
Mirtazapine versus amitriptyline in the long‐term treatment of depression: a double‐blind placebo‐controlled studyInternational Clinical Psychopharmacology, 13
A. Beck, C. Ward, M. Mendelson, J. Mock, J. Erbaugh (1961)
An inventory for measuring depression.Archives of general psychiatry, 4
B. Sadzot, C. Lemaire, P. Maquet, E. Salmon, A. Plenevaux, C. Degueldre, J. Hermanne, M. Guillaume, R. Cantineau, D. Comar, G. Franck (1995)
Serotonin 5HT2 Receptor Imaging in the Human Brain Using Positron Emission Tomography and a New Radioligand, [18F]Altanserin: Results in Young Normal ControlsJournal of Cerebral Blood Flow & Metabolism, 15
J. Sled, A. Zijdenbos, Alan Evans (1998)
A nonparametric method for automatic correction of intensity nonuniformity in MRI dataIEEE Transactions on Medical Imaging, 17
C. Stockmeier (2003)
Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter.Journal of psychiatric research, 37 5
P Bech, P Allerup, LF Gram, N Reisby, R Rosenberg, O Jacobsen, A Nagy (1981)
The Hamilton depression scale. Evaluation of objectivity using logistic modelsActa Psychiatr Scand, 63
A. Rush, S. Wisniewski, D. Warden, J. Luther, L. Davis, M. Fava, A. Nierenberg, M. Trivedi (2008)
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.Archives of general psychiatry, 65 8
J. Meyer, Alan Wilson, N. Ginovart, Verdell Goulding, D. Hussey, Karen Hood, S. Houle (2001)
Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.The American journal of psychiatry, 158 11
A. Collignon (1995)
Automated multimodality image registration using information theory
PET neuroimaging with ( 11 C)mirtazapine showed aberrant neuroreceptor binding in brain regions of depressed subjects who had failed to benefit from treatment with antidepressant drugs.
Psychopharmacology – Springer Journals
Published: Sep 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.